Anwar Haque

Anwar Haque

Auto-generated profile, based on publicly available information

Anwar Haque

Pediatrics, The Indus Hospital, Karachi, PAK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2011 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
NSNaveed- Ur-Rehman Siddiqui
Naveed- Ur-Rehman Siddiqui
RWRabia Wali
Rabia Wali
AHAnwar- Ul Haque
Anwar- Ul Haque
ZFZehra Fadoo
Zehra Fadoo
Introduction: Pediatric oncology patients are at increased risk of contracting healthcare-associated infections (HAIs), which are responsible for increased morbidity and mortality rates as well as treatment costs. This study aimed to identify the frequency of HAIs among pediatric oncology patients and their outcome. Methodology: Pediatric oncology patients admitted between January 2009 and June 2010 in a pediatric ward at Aga Khan University Hospital, Karachi, Pakistan, who developed HAIs, were analyzed. Results: A total of 90 HAIs were identified in 32 patients in 70 admissions. The HAI rate among pediatric oncology patients was 3.1/100 admission episodes. Bloodstream infections (63 episodes, 90.0%) were the most common, followed by urinary tract infection (two episodes, 2.9%). Gram-positive infections were seen in 54 (60%) patients, followed by Gram-negative infection in 34 (37.8%), and fungi in 2 (2.8%) cases. Coagulase negative staphylococci was the most common Gram-positive and Escherichia coli and Pseudomonas aeruginosa were most common Gram-negative infections. Mortality rate among pediatric oncology patients who developed HAIs was 12.5% (4/32). Total parental nutrition use and length of stay longer than 30 days were the identified risk factors associated with increased mortality among pediatric oncology patients who developed HAIs. Conclusion: We report an HAI rate among pediatric oncology patients of 3.1/100 admission episodes with a mortality rate of 12.5% in Pakistan. Further studies should be done, especially in the developing world, to identify the risk factors associated with increased mortality among pediatric oncology patients so that adequate measures can be taken to reduce the mortality among these patients.

28 March 2020 in Cureus
Verified
Journal Article
Open access
PDF file
SASaba Laila Aslam
Saba Laila Aslam
AHAnwar Haque
Anwar Haque
MJMuhammad Tariq Jamil
Muhammad Tariq Jamil
MAMadiha Ariff
Madiha Ariff
SNSaad Nasir
Saad Nasir
Procedural sedation and analgesia are the standard of care for painful procedures in children that require immobility. The aim is to assess the safety and efficacy of procedural sedation and analgesia in pediatric oncological patients in a large tertiary care hospital. An observational study performed to review medical records of children who received procedural sedation and analgesia (PSA) for pediatric oncological procedures from July 2018 to September 2018. Patients undergoing oncology procedures (lumbar puncture, intrathecal chemotherapy, bone marrow aspiration +/- trephine) were included, and non-anesthesiologist (intensive care physician/emergency physician certified in pediatric advanced life support) provided PSA. Patients were assessed according to PSA protocol guidelines by the American Society of Anesthesiology (ASA). Low-dose ketamine (0.5 mg/kg) and propofol (2 mg/kg) were administered. A total of 565 children underwent 1216 procedures in whom the median age was 7.4 years, and the majority (65.1%) were males. The most common procedure was the lumbar puncture (n = 956; 78.6%) followed by bone marrow aspirate only (n = 137, 11.3%) and both (n = 123, 10.1%). Eight (0.7%) patients developed transient oxygen desaturation only as an adverse effect of ketamine-propofol drug combination with 50% procedures utilizing propofol 1 mg/kg for sedation. According to the results of our study, the majority of the pediatric patients responded and reported no adverse events during the procedure with ketamine and propofol. Therefore, we conclude that ketamine and propofol are safe and effective as both sedative and an analgesic in procedures on pediatric oncology patients.

1 May 2014 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
NSN. Siddiqui
N. Siddiqui
AHA. Haque
A. Haque
LLLaila Akbar Akbar Ladak
Laila Akbar Akbar Ladak
MHM. Hamid
M. Hamid
SMS. Mirza
S. Mirza
ZBZ. Bhutta
Z. Bhutta

9 November 2023 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
CRC. Rupprecht
C. Rupprecht
SRS. Relangi
S. Relangi
DRD. Rana
D. Rana
AHA. Haque
A. Haque
Guha KrishnaswamyGuha Krishnaswamy
Guha Krishnaswamy